Publications by authors named "Subham Thakur"
Res Social Adm Pharm
August 2024
Article Synopsis
- Acute respiratory distress syndrome (ARDS) is a serious lung complication from COVID-19, and the study explored the use of oral beta-hydroxybutyrate (BHB) to reduce inflammation in affected patients.
- 75 patients with mild ARDS were randomly assigned to receive either BHB or placebo for five days, with the main goal of measuring changes in inflammatory cytokines.
- Results indicated that BHB significantly lowered pro-inflammatory cytokines, increased anti-inflammatory cytokines, and resulted in shorter hospital stays without serious side effects, suggesting it may be a promising treatment for ARDS.
